Uniphar Group PLC (UPR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Uniphar Group PLC (UPR) has a cash flow conversion efficiency ratio of -0.021x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.50 Million ≈ $-7.60 Million USD) by net assets (€304.14 Million ≈ $355.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see UPR stock market capitalisation for the company's overall valuation and market capitalisation.
Uniphar Group PLC - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Uniphar Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Uniphar Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Uniphar Group PLC ranked by their cash flow conversion efficiency. Explore UPR cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Hangmin Co Ltd
SHG:600987
|
-0.004x |
|
HMC Capital Ltd
AU:HMC
|
0.015x |
|
LianChuang Electronic Technology Co Ltd
SHE:002036
|
0.002x |
|
Shandong Intco Recycling Resources Co Ltd
SHG:688087
|
0.064x |
|
Suven Life Sciences Limited
NSE:SUVEN
|
-0.368x |
|
CTT Correios de Portugal SA
LS:CTT
|
0.199x |
|
Carlsberg Brewery Malaysia Bhd
KLSE:2836
|
0.636x |
|
Aksa Akrilik Kimya Sanayi AS
IS:AKSA
|
0.004x |
Annual Cash Flow Conversion Efficiency for Uniphar Group PLC (2016–2024)
The table below shows the annual cash flow conversion efficiency of Uniphar Group PLC from 2016 to 2024. View UPR share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €401.88 Million ≈ $469.84 Million |
€124.27 Million ≈ $145.28 Million |
0.309x | +96.46% |
| 2023-12-31 | €333.62 Million ≈ $390.04 Million |
€52.51 Million ≈ $61.39 Million |
0.157x | -44.93% |
| 2022-12-31 | €289.78 Million ≈ $338.79 Million |
€82.83 Million ≈ $96.84 Million |
0.286x | +37.81% |
| 2021-12-31 | €251.56 Million ≈ $294.10 Million |
€52.18 Million ≈ $61.00 Million |
0.207x | -36.33% |
| 2020-12-31 | €202.53 Million ≈ $236.78 Million |
€65.98 Million ≈ $77.14 Million |
0.326x | -44.92% |
| 2019-12-31 | €180.92 Million ≈ $211.51 Million |
€107.00 Million ≈ $125.09 Million |
0.591x | +1107.78% |
| 2018-12-31 | €148.90 Million ≈ $174.08 Million |
€-8.74 Million ≈ $-10.22 Million |
-0.059x | -137.39% |
| 2017-12-31 | €-10.72 Million ≈ $-12.54 Million |
€-1.68 Million ≈ $-1.97 Million |
0.157x | +106.76% |
| 2016-12-31 | €-10.20 Million ≈ $-11.92 Million |
€23.70 Million ≈ $27.70 Million |
-2.324x | -- |
About Uniphar Group PLC
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more